Hormonal Therapy Cost in Amroha

Hormone treatment blocks or lowers hormone levels to prevent or stop the growth of cancers that are sensitive to hormones, such as endometrial, prostate, or breast cancer. Additionally, it reduces symptoms and stops recurrence, particularly in hormone receptor-positive tumours that are early-stage or metastatic.

Consult a doctor if you experience unexplained weight changes, fatigue, abnormal bleeding, or symptoms related to hormone-sensitive organs. Reporting any new or worsening symptoms while receiving cancer therapy is important since immediate action can enhance treatment results.

Imaging scans, blood work, and hormone receptor testing (such as ER/PR for breast cancer) are all part of the preparation process. Your doctor will evaluate your existing medications, other medical issues, and menopausal status (for women). Lifestyle changes and side effect management plans may also be discussed before therapy begins.

Hormone therapy may be administered as oral tablets, injections, or in rare cases, surgery (e.g., ovarian removal). For breast cancer, certain inhibitors block estrogen & for prostate cancer, certain hormones are used as agonists/antagonists to reduce testosterone production or block its action.

Hormone therapy durations vary significantly depending on the purpose and the patient's needs.

• Hot flashes
• Fatigue & mood changes
• Sexual dysfunction
• Bone thinning or joint pain
• Blood clots

For hormone receptor-positive cancers, hormone therapy can enhance survival, lower the chance of recurrence, and delay or stop the growth of the malignancy. It is often less invasive and well-tolerated compared to chemotherapy or surgery.

While not a surgical treatment, hormone therapy involves long-term management of side effects such as hot flashes, weight gain, and mood swings. Patients need routine blood tests, bone density monitoring, emotional support, and lifestyle adjustments.

Depending on the kind and stage of the cancer, success varies. Hormone therapy dramatically increases survival rates, reducing the chance of recurrence in hormone-positive breast cancer by up to 50% and effectively controlling up to 90% of early-stage prostate tumours.